Neurocrine Biosciences, Inc. (NBIX) Competitors & Peers
The 5 largest companies in the same industry as Neurocrine Biosciences, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| JHPCY | Peer | $12.25 | P/E 37.1RSI 35Cap 81.3 B |
| GDERF | Peer | $228.30 | P/E 62.5RSI 56Cap 50.8 B |
| TAK | Peer | $20.80 | P/E 297.1RSI 63Cap 66.4 B |
| GALDY | Peer | $45.71 | P/E 53.5RSI 46Cap 45.5 B |
| TKPHF | Peer | $42.77 | RSI 49Cap 59.7 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- XENEPartner
Neurocrine partners with Xenon to license and co-develop seizure candidate NBI-921352.
Model-inferred, unverified — treat as a lead, not evidence